Nathaniel Mabe,PharmD,PhD retweeted
Now online: Inhibition of USP7 destabilizes the noncanonical PRC1.1 complex and induces neuroblastoma differentiation doi.org/10.1158/1541-7786.MC…
Proud to share the first article from the lab. Out now @MCR_AACR and linked in the comment, we show that USP7 inhibition destabilizes noncanonical PRC1 complexes to induce differentiation in neuroblastoma. Thank you to the collaborators and lab members!
1
6
164
During March madness, Purdue is putting a spotlight on pediatric cancer research and the many ways Purdue impacts our communities. Had fun helping with the project. Boiler up!
youtube.com/watch?v=u9PIysUz…
With 3 approved epigenetic drug classes and many more under clinical investigation, epigenetic targets are gaining traction. Here, we take survey of developments and hurdles in targeting the cancer epigenome. Thank you @NatureCancer for the opportunity
nature.com/articles/s43018-0…
New publication by #teamneuroblastoma in the @KStegmaier_DFCI lab in collaboration with the Dent lab at MD Anderson. science.org/doi/10.1126/scia…. Happy to have helped bring this one over the finish line after the work done by @clarebear1060 and @FormanAllie.
Today marks the close of the postdoc chapter. I am fortunate to have called the @KStegmaier_DFCI home for the last 5 years. It was a privilege to work alongside so many amazing and talented scientists throughout this journey. Thank you for all the good memories!
35
1,755
We'll be opening lab doors in May and are recruiting a research technician with a start in May or June. If you are interested in studying pediatric cancer please reach out or apply. careers.purdue.edu/job-invit… @Purdue_MCMP @PUCancerInst @purduepharmacy
Amazing news to hear on a football Saturday. Thank you Trent family for your support and advocacy. Very excited to help make pediatric cancer research a priority at Purdue.
Nearly 5 years after Tyler Trent’s passing from a rare bone cancer, #Purdue University is making sure the devoted Boilermaker football fan will live on through research to cure his disease. purdue.link/Tyler-Trent-Rese…
Nathaniel Mabe,PharmD,PhD retweeted
@Purdue_MCMP is hiring for Faculty Positions in Translational Neuroscience and Chemical Biology careers.purdue.edu/job-invit…
I'm thrilled to share that I’ll be joining @Purdue_MCMP @purduepharmacy @PUCancerInst @LifeAtPurdue as an assistant professor starting summer 2024. We’ll be studying the intersection of epigenetics, cell state, and therapeutics in pediatric solid tumors.
Very thankful to receive a K99/R00 to continue studying epigenetic mechanisms regulating therapy response in neuroblastoma. A big thank you to @theNCI who has supported me through all steps of my training.
Also a big thank you to my mentors over the years @KStegmaier_DFCI @alvarezlabhutch @Majzner_Lab and twitterless Boyd Rorabaugh. This wouldn't have been possible without your support.
Nathaniel Mabe,PharmD,PhD retweeted
🌟Long-awaited proof-of-concept that CAR-T can eradicate solid tumours - and in immune cold paediatric tumours. Brava, Locatelli and Precision Medicine Team at Ospedale Pediatrico Bambino Gesù!
nejm.org/doi/full/10.1056/NE…
Nathaniel Mabe,PharmD,PhD retweeted
Happy to share the newest paper from our lab. Led by technician extraordinaire Aidan Tousley (soon to be an MD/PHD student!), this manuscript details our attempts to reimagine the structure of CARs to improve their specificity and efficacy. rdcu.be/c7avS
Nathaniel Mabe,PharmD,PhD retweeted
Check out two new publications on Ewing sarcoma and ETV6 in @NatureCellBio from our lab and @ChrisVakoc. Excited to see them both in press!
doi.org/10.1038/s41556-022-0…
Nathaniel Mabe,PharmD,PhD retweeted
Online today in @CellCellPress! Our fab collaboration with @iaincheeseman lab: image-based screen 5K+ essential genes to build a resource defining the phenotypic consequences of disrupting core cellular processes @broadinstitute @WhiteheadInst @lukebfunk cell.com/cell/fulltext/S0092…
Nathaniel Mabe,PharmD,PhD retweeted
Holy cow! Open call for a Researcher position (MSc or PhD, no post-doc experience needed). This will person will be a part of the Pediatric Dependencies Project - a collaboration between @broadinstitute, @DFBC_PedCare and @StJudeResearch! Cool, right?
talent.stjude.org/careers/jo…














